Sinopharm
1099.HK
$2.78
Share price
0.69%
Change (1 day)
-20.57%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Earnings for Sinopharm (1099.HK)
Earnings in 2023 (TTM): $2.38 B
According to Sinopharm's latest financial reports the company's current earnings (TTM) are $3.20 B. In 2022 the company made an earning of $3.20 B a decrease over its 2021 earnings that were of $3.25 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Sinopharm from 2006 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $2.38 B | -25.4% |
| 2022 | $3.20 B | -1.72% |
| 2021 | $3.25 B | 11.7% |
| 2020 | $2.91 B | 18.44% |
| 2019 | $2.46 B | 10.85% |
| 2018 | $2.22 B | 3.05% |
| 2017 | $2.15 B | 36.48% |
| 2016 | $1.57 B | 7.11% |
| 2015 | $1.47 B | 12.38% |
| 2014 | $1.31 B | 25.05% |
| 2013 | $1.04 B | 22.54% |
| 2012 | $0.85 B | 35.43% |
| 2011 | $0.63 B | 52.24% |
| 2010 | $0.41 B | 30.99% |
| 2009 | $0.31 B | 60.59% |
| 2008 | $0.19 B | 48.29% |
| 2007 | $0.13 B | 123.29% |
| 2006 | $59.63 M |